Home
>
National Drug Code (NDC)
>
SEMPREX
SEMPREX - 52244-404-10 - (acrivastine and pseudoephedrine hydrochloride)
Drug Information of SEMPREX
| Product NDC: | 52244-404 |
| Proprietary Name: | SEMPREX |
| Non Proprietary Name: | acrivastine and pseudoephedrine hydrochloride |
| Active Ingredient(s): | 8; 60 mg/1; mg/1 & nbsp; acrivastine and pseudoephedrine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of SEMPREX
| Product NDC: | 52244-404 |
| Labeler Name: | Actient Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019806 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120126 |
Package Information of SEMPREX
| Package NDC: | 52244-404-10 |
| Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (52244-404-10) |
NDC Information of SEMPREX
| NDC Code | 52244-404-10 |
| Proprietary Name | SEMPREX |
| Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (52244-404-10) |
| Product NDC | 52244-404 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | acrivastine and pseudoephedrine hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120126 |
| Marketing Category Name | NDA |
| Labeler Name | Actient Pharmaceuticals, LLC |
| Substance Name | ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Strength Number | 8; 60 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
